Alpheus Medical Initiates Phase 2b Trial of Investigational Therapy for Newly Diagnosed Glioblastoma

The company has enrolled 10 patients, marking early momentum in evaluating a novel, non-invasive, drug-centered therapeutic approach to brain cancer treatment. CHANHASSEN, Minn., April 9, 2026 /PRNewswire/ -- Alpheus Medical, Inc., a private, clinical-stage biotechnology company, today...